Name | Number of supported studies | Average coverage | |
---|---|---|---|
type II pneumocyte | 11 studies | 55% ± 13% | |
macrophage | 11 studies | 28% ± 10% | |
classical monocyte | 7 studies | 21% ± 4% | |
type I pneumocyte | 6 studies | 21% ± 6% | |
monocyte | 6 studies | 28% ± 6% | |
non-classical monocyte | 6 studies | 22% ± 5% | |
myeloid cell | 6 studies | 25% ± 8% | |
fibroblast | 6 studies | 22% ± 5% | |
club cell | 4 studies | 30% ± 8% | |
endothelial cell | 4 studies | 21% ± 7% | |
epithelial cell | 3 studies | 20% ± 4% | |
alveolar macrophage | 3 studies | 26% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 8 studies | 23% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 1883.09 | 89 / 89 | 99% | 68.68 | 890 / 901 |
lung | 100% | 5835.89 | 578 / 578 | 98% | 69.19 | 1131 / 1155 |
stomach | 100% | 1632.93 | 359 / 359 | 96% | 25.26 | 274 / 286 |
breast | 100% | 1777.91 | 459 / 459 | 96% | 26.87 | 1070 / 1118 |
intestine | 99% | 1361.05 | 961 / 966 | 94% | 23.29 | 496 / 527 |
bladder | 100% | 1881.90 | 21 / 21 | 88% | 30.17 | 446 / 504 |
thymus | 99% | 1139.11 | 647 / 653 | 89% | 25.70 | 540 / 605 |
uterus | 100% | 1380.92 | 170 / 170 | 88% | 27.48 | 402 / 459 |
skin | 96% | 1600.48 | 1736 / 1809 | 90% | 25.69 | 424 / 472 |
esophagus | 95% | 1129.58 | 1377 / 1445 | 90% | 19.25 | 164 / 183 |
pancreas | 88% | 704.06 | 287 / 328 | 94% | 21.78 | 168 / 178 |
prostate | 100% | 1344.54 | 244 / 245 | 80% | 12.25 | 400 / 502 |
ovary | 100% | 947.96 | 180 / 180 | 73% | 11.43 | 316 / 430 |
adrenal gland | 100% | 1988.41 | 258 / 258 | 66% | 8.92 | 151 / 230 |
liver | 55% | 287.49 | 125 / 226 | 53% | 10.68 | 216 / 406 |
brain | 35% | 142.98 | 926 / 2642 | 69% | 11.42 | 489 / 705 |
adipose | 100% | 2159.81 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 57.31 | 29 / 29 |
spleen | 100% | 1442.22 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 32.78 | 1 / 1 |
blood vessel | 100% | 1368.80 | 1330 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 27.76 | 43 / 45 |
heart | 90% | 668.62 | 776 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 1889.32 | 764 / 929 | 0% | 0 | 0 / 0 |
muscle | 54% | 258.64 | 434 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 44% | 5.40 | 35 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006915 | Biological process | apoptotic process |
GO_0006914 | Biological process | autophagy |
GO_0010506 | Biological process | regulation of autophagy |
GO_0005764 | Cellular component | lysosome |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
Gene name | DRAM1 |
Protein name | DNA damage-regulated autophagy modulator protein 1 (Damage-regulated autophagy modulator) DNA damage regulated autophagy modulator 1 |
Synonyms | DRAM |
Description | FUNCTION: Lysosomal modulator of autophagy that plays a central role in p53/TP53-mediated apoptosis. Not involved in p73/TP73-mediated autophagy. . |
Accessions | ENST00000549365.1 H0YHV0 ENST00000549066.1 H0YHJ0 ENST00000551403.1 Q8N682 A0A0B4J256 ENST00000258534.13 [Q8N682-1] ENST00000544152.5 [Q8N682-2] |